Skip to main content
. 2011 May 5;27(1):166–173. doi: 10.1093/ndt/gfr218

Table 3.

Hazard ratios for incident stroke symptoms associated with level of albuminuriaa

Albuminuria category, mg/g
<10 (n = 13310) 10–29 (n = 4598) 30–299 (n = 2246) ≥300 (n = 440) P-trend
Any stroke symptom
    Hazard ratio 1 1 (ref) 1.22 (1.11–1.34) 1.43 (1.28–1.61) 1.49 (1.19–1.87) <0.001
    Hazard ratio 2 1 (ref) 1.13 (1.03–1.25) 1.25 (1.11–1.41) 1.10 (0.87–1.40) 0.002
Symptom—sudden weakness
    Hazard ratio 1 1 (ref) 1.16 (0.98–1.39) 1.41 (1.14–1.74) 1.48 (1.00–2.21) <0.001
    Hazard ratio 2 1 (ref) 1.11 (0.93–1.33) 1.23 (0.99–1.53) 1.09 (0.71–1.67) 0.133
Symptom—sudden numbness
    Hazard ratio 1 1 (ref) 1.25 (1.08–1.44) 1.34 (1.12–1.61) 1.26 (0.87–1.82) <0.001
    Hazard ratio 2 1 (ref) 1.17 (1.01–1.36) 1.16 (0.96–1.40) 0.92 (0.62–1.37) 0.334
Symptom—sudden painless loss of vision in one or both eyes
    Hazard ratio 1 1 (ref) 1.15 (0.95–1.38) 1.55 (1.25–1.93) 1.79 (1.20–2.67) <0.001
    Hazard ratio 2 1 (ref) 1.04 (0.86–1.25) 1.31 (1.04–1.64) 1.29 (0.84–1.96) 0.029
Symptom—sudden loss of half vision
    Hazard ratio 1 1 (ref) 1.30 (1.00–1.68) 1.70 (1.26–2.29) 1.51 (0.82–2.79) <0.001
    Hazard ratio 2 1 (ref) 1.13 (0.87–1.48) 1.39 (1.02–1.89) 0.95 (0.49–1.83) 0.222
Symptom—suddenly lost ability to understand people
    Hazard ratio 1 1 (ref) 1.28 (1.06–1.56) 1.46 (1.15–1.86) 2.34 (1.57–3.49) <0.001
    Hazard ratio 2 1 (ref) 1.19 (0.99–1.42) 1.26 (1.01–1.58) 1.70 (1.16–2.50) 0.002
Symptom—suddenly lost ability to express self verbally or in writing
    Hazard ratio 1 1 (ref) 1.25 (1.03–1.54) 1.36 (1.05–1.75) 1.35 (0.80–2.28) 0.005
    Hazard ratio 2 1 (ref) 1.17 (0.94–1.46) 1.20 (0.91–1.58) 1.02 (0.57–1.82) 0.289
a

Ref, reference category. Numbers in table are hazard ratio (95% CI). Hazard ratio 1 is adjusted for age, race, sex and geographic region. Hazard ratio 2 is adjusted for age, race, sex, geographic region, education, current smoking, alcohol consumption, BMI, systolic blood pressure, antihypertensive medication use, dyslipidemia, diabetes and elevated C-reactive protein.